You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 8, February 23, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Urinary Tract Disorders
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Estrogen Treatment for Urinary Incontinence

Never, Now, or in the Future?

Catherine E. DuBeau, MD

JAMA. 2005;293:998-1001.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Deciding whether to treat postmenopausal women with urinary incontinence (UI) with estrogen has become increasingly difficult. The literature is divided but generally supportive. A Cochrane systematic review concluded that "estrogen treatment can improve or cure incontinence," especially urge UI.1 Similarly, the International Consultation on Incontinence agreed in 2004 that "it seems reasonable to assume that estrogen therapy may be of benefit for the irritative symptoms of urinary urgency, frequency, and urge UI," but noted that estrogen had little role in the treatment of stress UI.2

However, in the Cochrane combined meta-analyses of randomized controlled trials, the overall number of participants was small (for example, for the outcome of subjective cure and improvement of UI, the analysis included 179 women assigned to estrogen and 177 women assigned to placebo from a total of 9 trials).1 Although the large prospective Heart and Estrogen/Progestin Replacement Study (HERS) (n = 1525) found . . . [Full Text of this Article]

Author Affiliation: Section of Geriatrics, University of Chicago, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effects of Estrogen With and Without Progestin on Urinary Incontinence
Susan L. Hendrix, Barbara B. Cochrane, Ingrid E. Nygaard, Victoria L. Handa, Vanessa M. Barnabei, Cheryl Iglesia, Aaron Aragaki, Michelle J. Naughton, Robert B. Wallace, and S. Gene McNeeley
JAMA. 2005;293(8):935-948.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Urinary Incontinence -- One More Purported Benefit of Hormone Therapy Disproved
JWatch Gastroenterology 2005;2005:6-6.
FULL TEXT  

Urinary Incontinence -- One More Purported Benefit of Hormone Therapy Disproved
JWatch General 2005;2005:1-1.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;330:501-502.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.